Russell Investments Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.38K Sell
4,451
-2,051
-32% -$2.02K ﹤0.01% 3478
2025
Q1
$9.36K Buy
6,502
+6,013
+1,230% +$8.66K ﹤0.01% 3250
2024
Q4
$1.08K Hold
489
﹤0.01% 3518
2024
Q3
$807 Buy
+489
New +$807 ﹤0.01% 3512
2024
Q2
Sell
-84,367
Closed -$226K 3597
2024
Q1
$226K Sell
84,367
-329
-0.4% -$882 ﹤0.01% 2411
2023
Q4
$253K Sell
84,696
-1,638
-2% -$4.9K ﹤0.01% 2385
2023
Q3
$84.6K Buy
86,334
+72,084
+506% +$70.6K ﹤0.01% 2656
2023
Q2
$19.8K Sell
14,250
-7,289
-34% -$10.1K ﹤0.01% 2841
2023
Q1
$34.2K Buy
21,539
+4,287
+25% +$6.82K ﹤0.01% 2763
2022
Q4
$107K Buy
+17,252
New +$107K ﹤0.01% 2660
2021
Q4
Sell
-94,505
Closed -$1.14M 3019
2021
Q3
$1.14M Buy
+94,505
New +$1.14M ﹤0.01% 2134
2021
Q2
Sell
-31,565
Closed -$884K 3238
2021
Q1
$884K Sell
31,565
-12,499
-28% -$350K ﹤0.01% 2299
2020
Q4
$1.15M Sell
44,064
-33,375
-43% -$868K ﹤0.01% 2058
2020
Q3
$2.88M Buy
77,439
+26,411
+52% +$981K 0.01% 1454
2020
Q2
$2.61M Sell
51,028
-1,559
-3% -$79.8K 0.01% 1483
2020
Q1
$1.66M Buy
52,587
+1,583
+3% +$49.9K ﹤0.01% 1563
2019
Q4
$3.04M Buy
51,004
+21,042
+70% +$1.25M 0.01% 1494
2019
Q3
$1.1M Buy
29,962
+29,276
+4,268% +$1.07M ﹤0.01% 1957
2019
Q2
$32K Buy
+686
New +$32K ﹤0.01% 2768
2019
Q1
Sell
-10,441
Closed -$480K 2933
2018
Q4
$480K Sell
10,441
-1,981
-16% -$91.1K ﹤0.01% 2333
2018
Q3
$551K Buy
12,422
+10,643
+598% +$472K ﹤0.01% 2352
2018
Q2
$69K Hold
1,779
﹤0.01% 2776
2018
Q1
$129K Sell
1,779
-665
-27% -$48.2K ﹤0.01% 2718
2017
Q4
$165K Sell
2,444
-22,628
-90% -$1.53M ﹤0.01% 2702
2017
Q3
$1.26M Buy
25,072
+1,913
+8% +$95.9K ﹤0.01% 2022
2017
Q2
$1.07M Sell
23,159
-4,054
-15% -$188K ﹤0.01% 2077
2017
Q1
$961K Buy
+27,213
New +$961K ﹤0.01% 2120